FONR.D

FONAR CORP

Healthcare · Diagnostics & Research

$70.35 sample

+0.09 (+0.13%) 1D

Market cap

$270.9B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-15

Alerts

8

Price$70.35 -7.52% 3M daily closessample

78.0069.45

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 15SEC10-Q filed
Oct 12SEC10-Q filed
Oct 05INSInsider sell: EVP, Operations
Sep 30INSInsider sell: EVP, Operations
Sep 25INSInsider buy: Chief Executive Officer
Sep 16INSInsider sell: EVP, Operations
Sep 10INSInsider buy: Chief Executive Officer
Sep 02INSInsider sell: Chief Financial Officer

Sign up to see the real FONR.D record →

Company facts

SEC EDGAR registration

Name: FONAR CORP
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in FONR.D

sample

Insiders: 7 insider transactions over 90 days, net selling, $179.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 26 funds hold $2.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.5B +19.0% y/y

Q4 2024Q3 2026

Inventory$5.9B +9.7% y/y

Q4 2024Q3 2026

Accounts receivable$4.4B +11.6% y/y

Q4 2024Q3 2026

Total debt$11.9B +10.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $224.6B -2.7% 3M
Sample peer B: $202.8B -2.1% 3M
Sample peer C: $35.9B +6.0% 3M
Sample peer D: $52.5B +10.3% 3M
Sample peer E: $227.2B -5.5% 3M